Lefty,
Trump is an American Mano.
You are not.
The
Lefty,
Trump is an American Mano.
You are not.
The bad boyz out there are on their heels with him.
They were eating you alive sport.
The common sense people have a fighting chance now.
Because you have had your way for decades, do not
underestimate the fight you are in. It won't be pretty.
Part of your delusion is that you are of the correct and
we are to be commanded further. oops. Not !!
Oh man,
there is to be a 2nd and 3rd wave
of the silent majority to come. wow.
Finally I might say.
And likely in time to actually change
the direction of things.
1
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...
Continue Reading
Understanding the Invisible Threat of Crawl Space Mold Crawl space mold—it hides in the shadows beneath your home, biding its time until it wreaks havoc on indoor air quality. In the context of New Jersey's environmental quirks, this isn't a trivial concern. With humidity hanging around like an unwanted guest and sneaky water intrusions, those dark nooks under houses...
Continue Reading
The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...
Continue Reading
A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...
Continue Reading
Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...
Continue Reading
De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...
Continue Reading
Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...
Continue Reading
Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...
Continue Reading
Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...
Continue Reading
What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...
Continue Reading
Top 5 Most Recently Viewed Articles
Grindr Inc. Investigation Overview Grindr Inc. is currently facing a significant investigation concerning its board of directors, primarily focused on potential breaches of fiduciary duties. The investigation is centered around a proposed deal that could notably affect the interests of minority shareholders. This situation raises essential questions about the obligations...
Continue Reading
Back in 2024, Abridge launched its Research Collaborative to dive into how ambient AI could shake up the healthcare game. They weren’t just throwing darts blindfolded; they aimed at some key issues: improving clinician and patient experiences, cutting down on costs, boosting outcomes, and promoting health equity. You know how it is—everyone’s talking about...
Continue Reading
Education Cannot Wait's Commitment to Gender Equality In a powerful move to bolster gender equality in education, Education Cannot Wait (ECW) has launched groundbreaking grants totaling $1.9 million. This funding aims to support girls who often encounter substantial barriers in accessing quality education during emergencies and prolonged crises. Partnerships for Change...
Continue Reading
Vaccinex’s Stock Drop and Ongoing Developments This past year has been quite tough for Vaccinex, Inc. (NASDAQ: VCNX), a biotech company focused on improving patient care with innovative therapies. Recently, its stock has fallen to a notable 52-week low of $4.17, marking a dramatic 75.4% drop over the year. This decline reflects not just numbers but also growing concerns...
Continue Reading
RenovoRx Boosts Scientific Expertise with New Board Member RenovoRx, Inc. (NASDAQ: RNXT), a pioneering life sciences company focused on advancing targeted oncology therapies, is excited to announce the addition of Dr. Thierry de Baère, an acclaimed interventional oncologist, to its Scientific Advisory Board (SAB). This strategic move underscores the company’s...
Continue Reading